1Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med, 2000, 342: 15-20.
2Schrag S J, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med, 2002, 347 : 233-239.
3Heath PT, Balfour G, Weisner AM, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet, 2004,363 : 292-294.
5Tamayo J, Gomez-Garces JL, Alos JI. Evaluation of Granada agar plate for detection of Streptococcus agalactiae in urine specimens from pregnant women. J Clin Microbiol, 2004, 42: 3834-3836.
6Baker CJ. Inadequacy of rapid immunoassays for intrapartum detection of group B streptococcal carriers. Obstet Gynecol, 1996,88 : 51-55.
7Department of Health and Human Services. Risks of devices for direct detection of group B streptococcal antigen. J Nurse Midwifery,1997, 42: 408-409.
8Artz LA, Kempf VA, Autenfieth IB. Rapid screening for Streptococcus agalactiae in vaginal specimens of pregnant women by fluorescent in situ hybridization. J Clin Microbiol, 2003,41: 2170-2173.
9Maeland JA, Brakstad OG, Bevanger L, et al. Distribution and expression of bca, the gene encoding the c alpha protein, by Streptococcus agalactiae. J Med Microbiol, 2000, 49: 193-198.
10Dmitriev A, Suvorov A, Shen AD, et al. Clinical diagnosis of group B streptococci by scpB gene based PCR. Indian J Med Res, 2004,119 Suppl: 233-236.
